1-3 of 3
Douglas D. Ross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Vorinostat Combined with Cytarabine and Etoposide in Patients (pts) with Advanced Acute Leukemia and High-Risk Myelodysplastic Syndromes

Ivana Gojo, MD, Ming T. Tan, PhD, Ken Shiozawa, MD, PhD, Takeo Nakanishi, PhD, Angelika M Burger, PhD, Colette L Burgess, BS, Merrill J Egorin, MD, Maria R. Baer, MD, Michael L Tidwell, RN, CRNP, Rakesh Srivastava, PhD, France Carrier, PhD, Angela Scardina, RN, Igor Espinoza-Delgado, MD, Douglas D. Ross, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4011.
https://doi.org/10.1182/blood.V112.11.4011.4011
Published: 2008
Journal Articles

Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL–expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression

Takeo Nakanishi, Ken Shiozawa, Bret A. Hassel, Douglas D. Ross
Journal: Blood
Blood (2006) 108 (2): 678–684.
https://doi.org/10.1182/blood-2005-10-4020
Published: 2006
Journal Articles

Expression of breast cancer resistance protein in blast cells from patients with acute leukemia: Presented in part at the Fortieth Annual Meeting of the American Society of Hematology, Miami Beach, FL, December 4-8, 1998.

Brief Report
Douglas D. Ross, Judith E. Karp, Tar T. Chen, L. Austin Doyle
Journal: Blood
Blood (2000) 96 (1): 365–368.
https://doi.org/10.1182/blood.V96.1.365
Published: 2000